Duncan Williams Downgrades Cadence Pharma (CADX) to Buy; Tortoise But the Street Expects a Hare
Tweet Send to a Friend
Duncan Williams downgraded Cadence Pharma (NASDAQ: CADX) from Strong Buy to Buy, price target lowered from $14 to $12.
Duncan ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Duncan ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
